| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.641 | 12.596 | 12.842 | 13.268 | 19.725 | 26.979 | 43.526 | 61.941 | 92.860 | 93.858 |
| Total Income - EUR | 5.641 | 12.596 | 12.842 | 13.268 | 19.725 | 27.309 | 50.620 | 63.973 | 93.186 | 93.859 |
| Total Expenses - EUR | 1.655 | 8.675 | 7.084 | 7.944 | 10.464 | 9.593 | 10.627 | 14.300 | 27.759 | 28.542 |
| Gross Profit/Loss - EUR | 3.987 | 3.921 | 5.758 | 5.324 | 9.261 | 17.716 | 39.993 | 49.674 | 65.428 | 65.317 |
| Net Profit/Loss - EUR | 3.817 | 3.543 | 4.998 | 4.926 | 8.669 | 16.959 | 38.798 | 48.206 | 64.593 | 62.839 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gynecology Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 692 | 10.376 | 7.572 | 5.137 | 5.519 | 1.698 | 3.195 | 26.855 | 22.299 | 15.890 |
| Current Assets | 4.479 | 3.307 | 4.180 | 4.985 | 10.350 | 54.572 | 77.472 | 65.902 | 76.805 | 75.946 |
| Inventories | 0 | 0 | 0 | 0 | 94 | 93 | 91 | 91 | 91 | 0 |
| Receivables | 0 | 0 | 204 | 316 | 8.955 | 44.705 | 71.120 | 52.446 | 73.413 | 66.163 |
| Cash | 4.479 | 3.307 | 3.976 | 4.669 | 1.301 | 9.775 | 6.261 | 13.365 | 3.302 | 9.783 |
| Shareholders Funds | 3.862 | 7.366 | 7.423 | 7.485 | 10.741 | 22.327 | 54.970 | 48.597 | 65.130 | 63.878 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.309 | 6.317 | 4.329 | 2.637 | 5.129 | 32.107 | 25.697 | 44.161 | 33.975 | 27.958 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 1.836 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gynecology Line Srl